Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-05T12:23:59.318Z Has data issue: false hasContentIssue false
  • English
  • Français

Zinc and taurine in Freidreich's ataxia

Published online by Cambridge University Press:  18 September 2015

D. Shapcott ,
R. Giguère  and
B. Lemieux
D. Shapcott
Affiliation:
Département de Pédiatrie, Université de Sherbrooke
R. Giguère
Affiliation:
Département de Pédiatrie, Université de Sherbrooke
B. Lemieux
Affiliation:
Département de Pédiatrie, Université de Sherbrooke
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Zinc and taurine were measured in urine in the fasting state and following a 4mg/kg load of taurine in subjects with Friedreich's Ataxia (FA), and healthy controls (C), and subjects with Duchenne type muscular dystrophy (MD). Of the FA, 25% had increased fasting excretion of zinc, and 50% had increased excretion of zinc following the taurine load. The MD subjects all had increased zinc excretion at all times. The increased zinc excretion did not correlate with increased excretion of taurine. As an index of zinc deficiency, uptake of zinc by erythrocytes was measured in all subjects and in heterozygotes for FA. The pattern of uptake was abnormal for FA and heterozygotes. Hair analysis for zinc showed that 10 of the 12 FA subjects had low values.

We conclude that significant abnormalities in zinc metabolism exist in some, but not all cases of FA. The evidence available does not permit definition of the cause of these abnormalities, whether zinc deficiency or abnormal zinc transport is the primary factor.

Type
C—Biochemistry
Information
Canadian Journal of Neurological Sciences , Volume 11 , Issue S4 , November 1984 , pp. 623 - 625
Copyright
Copyright © Canadian Neurological Sciences Federation 1984

References

Anon, (1978) A radical approach to zinc. Lancet 1: 191.Google Scholar
Barbeau, A (1982) Friedreich’s disease 1982: Etiologic hypotheses — A personal analysis. Can J Neurol Sci 9: 243–263.CrossRefGoogle ScholarPubMed
Barbeau, A, Donaldson, J (1974) Zinc, taurine and epilepsy. Arch Neurol 30: 52–58.CrossRefGoogle ScholarPubMed
Berry, RK, Bell, MD, Wright, PL (1966) Uptake of zinc by erythrocytes: effects of zinc deficiency. J Nutr 88: 284–287.CrossRefGoogle Scholar
Butterfield, DA, Markesbury, WR (1980) Specificity of biochemical and biophysical alterations in erythrocyte membrane in neurological disorders. J Neurol Sci 47: 261–264.CrossRefGoogle ScholarPubMed
Huang, YS, Marcel, YL, Vezina, C, Barbeau, A, Davignon, J (1980) Lecithin: cholesterol acyltransferase activity and fatty acid composition of erythrocyte phospholipids in Friedreich’s ataxia. Can J Neurol Sci 7: 429–434.CrossRefGoogle ScholarPubMed
Johnson, DJ, Djuh, Yin-Ying (1977) Improved colorimetric determination of serum zinc. Clin Chem 23: 1321–1323.CrossRefGoogle ScholarPubMed
Prasad, AS (1982) Clinical disorders of zinc deficiency. In: (Prasad, A, Dreosti, I, and Hetzel, BS, eds), Clinical application of recent advances in zinc metabolism, New York, A.R. Liss, pp 89–95.Google Scholar
Sandstead, HH, Vo-Khactu, KP, Solomons, N (1976) Conditioned zinc deficiencies. In: (Prasad, AS, and Oberlease, D, eds), Trace Elements in Human Health and Disease, New York, Academic Press, pp 33–.Google Scholar
Shapcott, D (1982) Hair and plasma in diagnosis of deficiency. In: (Prasad, AS, Dreosti, I, and Hetzel, B, eds), Clinical applications of recent advances in zinc metabolism, New York, A.R. Liss, pp 121–126.Google Scholar
Shapcott, D, Khoury, KK (1977) The measurement of volatile chromium in biological materials. Clin Biochem 10: 178–180.CrossRefGoogle ScholarPubMed